🇺🇸 FDA
Patent

US 11749394

Method and apparatus for providing a pharmacokinetic drug dosing regimen

granted A61KA61K49/0004A61P

Quick answer

US patent 11749394 (Method and apparatus for providing a pharmacokinetic drug dosing regimen) held by Takeda Pharmaceutical Company Limited expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K49/0004, A61P, A61P7/04